Page 8 - Cancer Drugs

AstraZeneca agrees to pay Japan's Daiichi $6 bn for new cancer drug

The UK drugmaker will pay Japan's Daiichi $1 billion upfront to jointly develop and bring to market a cancer therapy in early clinical tests called DS-1062, the companies said

Natco Pharma's Canadian unit, Celgene sign pact for cancer treatment drug

Lenalidomide drug is used to treat various types of cancers by slowing or stopping the growth of aberrant cells

Cancer drug with new process on slowing DNA repair shows promise in trial

The clinical trial led by investigators at the Dana-Farber Cancer Institute was detailed in the journal The Lancet Oncology

AstraZeneca plans to test new cancer medicine in coronavirus battle

The treatment for lymphoma may lessen the severity of respiratory distress by reducing the inflammation caused by the new coronavirus

WHO forecasts 81% cancer jump in poorer countries over lacking investments

The Geneva-based World Health Organization (WHO) said in a report that these countries had focused their limited resources on combating infectious diseases and improving maternal and child health

Cancer-fighting potential in nearly 50 drugs for other conditions: Study

"We found that a surprising number of non-oncology drugs are able to kill cancer cell lines in the lab," said Steven Corsello of Dana-Farber Cancer Institute

How a 31-year-old woman is spreading awareness among other cancer sufferers

Now 31, Saima Thompson is juggling a busy working life at the family restaurant, Masala Wala Cafe in Brockley, with encouraging debate about cancer in the black, Asian and minority ethnic communities

Aspirin may reduce tumour growth and lower bowel cancer risk: Study

According to the researchers, aspirin has the potential to prevent diseases that result from chronic inflammation, such as cancer, Alzheimer's, Parkinson's, and arthritis

Cancer drugs may be effective in treating chronic lung inflammation: Study

Researchers, including those from the University of Sheffield in the UK, assessed the effect of drugs used to treat different cancer types on lung damage in people living with COPD

Gene therapy to conquering hepatitis C: A decade of medical breakthroughs

Putting aside prices for a moment, it's been an exciting period for medical progress

HIVEC is next big step to prevent recurrence in superficial bladder cancer

Currently, bladder cancer in India is treated with Bacillus Calmette-Guerin (BCG) intravesical immunotherapy

Fighting Breast cancer: Follow these 7 steps apart from the treatment

This includes keeping your weight in check, being physically active, eating fruits and vegetables, avoid alcohol and cigarettes, etc

How to identify symptoms of breast cancer in both Women and Men

Breast cancer originates in the breast tissue when cells start growing abnormally and stop functioning like normal cells

Sun Pharma ties up with AstraZeneca to sell novel oncology drugs in China

Sun Pharma has been working out deals through this year to gain foothold in the Chinese market

Sun Pharma, Britain's AstraZeneca join to distribute cancer drugs in China

The financial terms of the agreement, which has an initial tenure of 10 years, were not disclosed

Pfizer raises 2019 forecast as sales of cancer drug, heart medicine surge

Excluding special items, Pfizer earned 75 cents per share, topping analysts' average estimate by 13 cents

Ranitidine cancer threat: Expect more clarity on products in coming weeks

Ranitidine sales account for 2 per cent of Strides sales and 6 per cent of its profit after tax

Bills for pills: Antibiotics could be govt's next segment for price cap

Centre likely to consider rationalising trade margins

Why aren't cancer drugs better? The targets might be wrong

Drugs can stop cancer cells if they attack the right proteins. But a new study suggests many of these targets were chosen with dated, imprecise technology, writes Carl Zimmer

Telangana businessman claims credit for cap on retail price of cancer drugs

Tractor dealer Purushottam Somani contacted PMO after finding difference of up to 1,000 per cent between wholesale price and MRP, says diabetes and other drugs next on radar